OpenAlex
PricingAboutJobs
Log inGet started
Work

AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts

HTML

Year: 2009
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-08-0836
Authors: Kate F. Byth, Andrew Thomas, Gareth Hughes, Cheryl Forder, Alexandra McGregor, Catherine Geh, Sandra Oakes, Clive Green, Mike Walker, Nicholas Newcombe, Stephen Green, Jim Growcott, Andy Barker, Robert W. Wilkinson
Language: English

Topic: Cancer-related Molecular Pathways
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cyclin-dependent kinase inhibitors, CDK1, CDK2, CDK9, tumor xenografts, cell cycle dysregulation, retinoblastoma protein phosphorylation, nucleolin, G2/M cell cycle arrest, dosing regimen, pharmacodynamics
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2103501749
FWCI: 1.453
Cites: 53
Cited by: 135
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security